SynthesisFrontiers in immunology2024

Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy followed by adjuvant immunotherapy in resectable non-small cell lung cancer: a meta-analysis of phase 3 clinical trials.

Wenjing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.